This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Gender factors

Authoring team

Certain cancers are selective for a given gender due to the presence of a gender-specific organ, e.g. cancer of the uterine cervix in females and cancer of the prostate in males. However, for other cancers with a common target, there exists a definite dichotomy in epidemiological features:

  • the majority of tumours have a higher incidence and mortality in males than females
  • only tumours of the breast, gallbladder, right side of the colon, genital tract and thyroid have a higher incidence in females
  • cancer of the breast is many hundreds of times more common in females than males, presumably because of the average greater volume of tissue which has a sustained exposure to physiological hormonal cycles
  • cancer of the lung in females is increasing, probably because of an increase in smoking in this group; however, it is still less than male rates and this may be partly due to a genetic predisposition: lung cancer rates in male non-smokers are approximately 50% greater than female non-smoker counterparts
  • some cancers have an extremely variable sex ratio depending on the age group and country examined, e.g. cancer of the oropharynx

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.